Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression.
Cancer Immunol Res
; 11(6): 763-776, 2023 06 02.
Article
in En
| MEDLINE
| ID: mdl-36921098
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glioblastoma
/
Glioma
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Cancer Immunol Res
Year:
2023
Document type:
Article
Country of publication:
United States